J Clin Exp Hepatol. 2015 Mar;5:S54-9. doi: 10.1016/j.jceh.2014.06.005. Epub 2014 Jul 31.
Diagnosis of minimal hepatic encephalopathy.
Journal of clinical and experimental hepatology
Karin Weissenborn
Affiliations
Affiliations
- Department of Neurology, Hannover Medical School, 30623 Hannover, Germany.
PMID: 26041959
PMCID: PMC4442856 DOI: 10.1016/j.jceh.2014.06.005
Abstract
Minimal hepatic encephalopathy (mHE) has significant impact upon a liver patient's daily living and health related quality of life. Therefore a majority of clinicians agree that mHE should be diagnosed and treated. The optimal means for diagnosing mHE, however, is controversial. This paper describes the currently most frequently used methods-EEG, critical flicker frequency, Continuous Reaction time Test, Inhibitory Control Test, computerized test batteries such as the Cognitive Drug Research test battery, the psychometric hepatic encephalopathy score (PHES) and the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS)-and their pros and cons.
Keywords: CDR, cognitive drug research; CFF, critical flicker frequency; CRT, continuous reaction time test; EEG, electroencephalography; ICT, inhibitory control test; PHES, psychometric hepatic encephalopathy score; PSE, portosystemic encephalopathy; RBANS, repeatable battery for the assessment of neuropsychological status; TA, target accuracy; WL, weighted lures; diagnostic means; diagnostic use; mHE, minimal hepatic encephalopathy; minimal hepatic encephalopathy; sensitivity; specificity
References
- J Gastroenterol Hepatol. 2012 Nov;27(11):1695-704 - PubMed
- Gastroenterology. 2010 Aug;139(2):510-8, 518.e1-2 - PubMed
- Clin Gastroenterol Hepatol. 2011 Jul;9(7):613-6.e1 - PubMed
- Metab Brain Dis. 2012 Dec;27(4):559-65 - PubMed
- Hepatology. 2002 Feb;35(2):357-66 - PubMed
- Eur J Gastroenterol Hepatol. 2009 Dec;21(12):1383-94 - PubMed
- J Hepatol. 2008 Sep;49(3):346-53 - PubMed
- Hepatology. 2013 Sep;58(3):844-6 - PubMed
- Arch Clin Neuropsychol. 2007 Feb;22(2):175-86 - PubMed
- Metab Brain Dis. 1998 Dec;13(4):361-77 - PubMed
- Med Clin (Barc). 2006 Jul 15;127(7):246-9 - PubMed
- Gastroenterology. 2011 Nov;141(5):1680-9.e1-2 - PubMed
- Hepatology. 2002 Mar;35(3):716-21 - PubMed
- Liver Int. 2009 May;29(5):629-35 - PubMed
- J Gastroenterol Hepatol. 2010 Jun;25(6):1029-41 - PubMed
- Dig Dis Sci. 2011 Oct;56(10):3014-23 - PubMed
- Electroencephalogr Clin Neurophysiol. 1984 May;57(5):423-6 - PubMed
- Dig Dis Sci. 2010 Aug;55(8):2381-90 - PubMed
- Liver Int. 2013 Nov;33(10):1478-89 - PubMed
- Eur J Gastroenterol Hepatol. 2013 Jan;25(1):77-84 - PubMed
- Trans Am Neurol Assoc. 1950;51:161-5 - PubMed
- Gastroenterology. 2008 Nov;135(5):1591-1600.e1 - PubMed
- Metab Brain Dis. 2002 Mar;17 (1):29-40 - PubMed
- Metab Brain Dis. 2013 Jun;28(2):239-43 - PubMed
- Hepatology. 2011 Feb;53(2):558-66 - PubMed
- Fortschr Neurol Psychiatr Grenzgeb. 1967 Apr;35(4):174-234 - PubMed
- J Hepatol. 2001 May;34(5):768-73 - PubMed
- Electroencephalogr Clin Neurophysiol. 1990 Apr;75(4):289-95 - PubMed
- Hepatology. 2012 Jun;55(6):1922-30 - PubMed
- Transplant Proc. 2006 Dec;38(10):3559-60 - PubMed
- Metab Brain Dis. 2011 Jun;26(2):135-9 - PubMed
- Scand J Gastroenterol. 1981 Apr;16(3):441-7 - PubMed
- J Hepatol. 2007 Mar;46(3):447-58 - PubMed
- Hepatology. 2007 Apr;45(4):879-85 - PubMed
- Gut. 2013 Oct;62(10):1394 - PubMed
- Gut. 2013 Oct;62(10):1497-504 - PubMed
- Metab Brain Dis. 2013 Jun;28(2):249-59 - PubMed
- J Clin Invest. 1955 Jun;34(6):790-9 - PubMed
- Liver Int. 2013 Oct;33(9):1332-40 - PubMed
- Am J Gastroenterol. 2007 Apr;102(4):754-60 - PubMed
- Lancet. 1957 Nov 2;273(7001):867-71 - PubMed
- Hepatology. 2013 Sep;58(3):1122-32 - PubMed
- J Gastroenterol Hepatol. 2013 Jul;28(7):1187-93 - PubMed
- J Gastroenterol Hepatol. 1995 Jan-Feb;10(1):14-23 - PubMed
- Psychiatry Clin Neurosci. 2006 Apr;60(2):174-81 - PubMed
- Acta Pharmacol Toxicol (Copenh). 1984 Feb;54(2):115-9 - PubMed
- Gastroenterology. 2008 Nov;135(5):1582-90 - PubMed
Publication Types